A technology and product development company. Established in 1986, the company has launched a number of new technologies and breakthrough products in global markets. It employs more than 200 staff and has offices worldwide.
Sagentia is a science, technology and product development company that helps maximize the value of investments in R&D and technology. We’ve been partnering with the likes of Johnson & Johnson, Smith & Nephew and Instrumentation Laboratory, as well as innovative start-ups like Senseonics and T2 Biosystems, for 30 years, helping them to understand their technology landscape, choose their innovation strategy, solve complex development challenges and ultimately to deliver commercially successful products that make a difference.
Our people (over 250 market experts, scientists and engineers) thrive on applying science & technology in new ways to develop solutions that are not only safe and effective, but crucially that give the best possible experience for the user (whether patient, medical professional or caregiver). This can involve anything from helping you to solve a specific science and technology challenge, through to a comprehensive design and development program.
Our expertise spans the patient care continuum and includes in vitro diagnostic devices, surgical instruments, advanced drug delivery technologies, and connected health applications. Some of the areas we’ve worked on recently include:
- Robotics and smart technologies in surgery
- Novel drug delivery devices and adherence monitoring methods
- Connected active implantables and patient monitoring systems
- Next Generation Sequencing technologies and troubleshooting the chemistry/instrument interaction
We’re curious and creative in how we approach these challenges, but we also understand the stringent needs of this highly regulated environment and are ISO 13485 accredited for medical device development. And we have long standing relationships with a clinicians, teaching hospitals and academia, making our insights and recommendations even richer.
Get in touch to discuss your next medical technology innovation.